A Double‐Blind, Randomized, Controlled Trial of Amphotericin B Colloidal Dispersion versus Amphotericin B for Treatment of Invasive Aspergillosis in Immunocompromised Patients
Open Access
- 15 August 2002
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 35 (4), 359-366
- https://doi.org/10.1086/341401
Abstract
We report a randomized, double-blind, multicenter trial in which amphotericin B colloidal dispersion (ABCD [Amphotec]; 6 mg/kg/day) was compared withKeywords
This publication has 22 references indexed in Scilit:
- The Effect of Prophylactic Fluconazole on the Clinical Spectrum of Fungal Diseases in Bone Marrow Transplant Recipients with Special Attention to Hepatic Candidiasis: An Autopsy Study of 355 PatientsMedicine, 1998
- Epidemiology ofAspergillusInfections in a Large Cohort of Patients Undergoing Bone Marrow TransplantationThe Journal of Infectious Diseases, 1997
- Antifungal Agents Used for Deep-Seated Mycotic InfectionsMayo Clinic Proceedings, 1992
- Novel antifungal drug delivery: stable amphotericin B-cholesteryl sulfate discsInternational Journal of Pharmaceutics, 1991
- Pharmacokinetic Study of a Novel Amphotericin B Colloidal Dispersion with Improved Therapeutic IndexAnnals of the New York Academy of Sciences, 1991
- Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: a 9-year study.Journal of Clinical Oncology, 1991
- Drug-Induced Nephrotoxicity Aetiology, Clinical Features and ManagementDrug Safety, 1991
- Antifungal and Surgical Treatment of Invasive Aspergillosis: Review of 2,121 Published CasesClinical Infectious Diseases, 1990
- Amphotericin B: 30 Years of Clinical ExperienceClinical Infectious Diseases, 1990
- ACUTE RENAL TOXICITY WITH COMBINED USE OF AMPHOTERICIN B AND CYCLOSPORINE AFTER MARROW TRANSPLANTATIONTransplantation, 1983